In the BioHarmony Drug Report Database

"Preview" Icon

Mometasone

Asmanex Hfa, Asmanex Twisthaler, Elocon, Nasonex, Sinuva, Zimbus Breezhaler (mometasone furoate) is a small molecule pharmaceutical. Mometasone furoate was first approved as Asmanex Hfa on 1987-04-30. It is used to treat allergic rhinitis perennial, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA. It has been approved in Europe to treat asthma. Elocon’s patents are valid until 2034-11-24 (FDA).

 

Trade Name

 

Zimbus Breezhaler
 

Common Name

 

mometasone furoate
 

ChEMBL ID

 

CHEMBL1161
 

Indication

 

allergic rhinitis perennial, asthma, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, pruritus, scalp dermatoses
 

Drug Class

 

Corticosteroid; Glucocorticoid

Image (chem structure or protein)

Mometasone structure rendering